These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2219209)

  • 1. Cerebral blood flow in experimental ischemia assessed by 19F magnetic resonance spectroscopy in cats.
    Brunetti A; Nagashima G; Bizzi A; DesPres DJ; Alger JR
    Stroke; 1990 Oct; 21(10):1439-44. PubMed ID: 2219209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in RCBF and edema after transient cerebral ischemia--ischemic threshold of postischemic hypoperfusion].
    Ikeda J; Hirakawa K; Nowak T; Klatzo I
    No To Shinkei; 1990 Oct; 42(10):951-7. PubMed ID: 2288774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving focal cerebral ischemia in cats: spatial correlation of nuclear magnetic resonance imaging, cerebral blood flow, tetrazolium staining, and histopathology.
    Bose B; Jones SC; Lorig R; Friel HT; Weinstein M; Little JR
    Stroke; 1988 Jan; 19(1):28-37. PubMed ID: 3336899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 19F NMR imaging of cerebral blood flow.
    Branch CA; Helpern JA; Ewing JR; Welch KM
    Magn Reson Med; 1991 Jul; 20(1):151-7. PubMed ID: 1943655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral blood flow measured by NMR indicator dilution in cats.
    Ewing JR; Branch CA; Helpern JA; Smith MB; Butt SM; Welch KM
    Stroke; 1989 Feb; 20(2):259-67. PubMed ID: 2645693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The competitive NMDA antagonist, CGS-19755, improves postischemic hypoperfusion in selectively vulnerable regions in gerbils.
    Omae T; Hasegawa Y; Ogata J; Tamaki K; Minematsu K; Yamaguchi T
    J Neurol Sci; 1996 Jun; 138(1-2):105-13. PubMed ID: 8791247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicity of a nuclear magnetic resonance cerebral blood flow indicator in cats.
    Branch CA; Ewing JR; Fagan SC; Goldberg DA; Welch KM
    Stroke; 1990 Aug; 21(8):1172-7. PubMed ID: 2389297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reperfusion of focal ischemia of varying duration: postischemic hyper- and hypo-perfusion.
    Traupe H; Kruse E; Heiss WD
    Stroke; 1982; 13(5):615-22. PubMed ID: 7123593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atraumatic quantitation of cerebral perfusion in cats by 19F magnetic resonance imaging.
    Branch CA; Ewing JR; Helpern JA; Ordidge RJ; Butt S; Welch KM
    Magn Reson Med; 1992 Nov; 28(1):39-53. PubMed ID: 1435220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 19F magnetic resonance imaging of cerebral blood flow with 0.4-cc resolution.
    Pekar J; Ligeti L; Sinnwell T; Moonen CT; Frank JA; McLaughlin AC
    J Cereb Blood Flow Metab; 1994 Jul; 14(4):656-63. PubMed ID: 8014213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of postischemic reperfusion with alpha-PBN: assessment using NMR and Doppler flow techniques.
    Schulz JB; Panahian N; Chen YI; Beal MF; Moskowitz MA; Rosen BR; Jenkins BG
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1986-95. PubMed ID: 9139987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of postischemic hypoperfusion on vasodilatory mechanisms in cats.
    Clavier N; Kirsch JR; Hurn PD; Traystman RJ
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H2012-8. PubMed ID: 7977832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency of cerebral blood flow and evoked potential alterations with reversible focal ischemia in cats.
    Matsumiya N; Koehler RC; Traystman RJ
    Stroke; 1990 Jun; 21(6):908-16. PubMed ID: 2349595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse cerebral ischemia in the cat: I. Local blood flow during severe ischemia and recirculation.
    Ginsberg MD; Budd MW; Welsh FA
    Ann Neurol; 1978 Jun; 3(6):482-92. PubMed ID: 677814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats.
    Takahashi H; Kirsch JR; Hashimoto K; London ED; Koehler RC; Traystman RJ
    Stroke; 1995 Sep; 26(9):1676-82. PubMed ID: 7544928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tirilazad treatment does not decrease early brain injury after transient focal ischemia in cats.
    Takeshima R; Kirsch JR; Koehler RC; Traystman RJ
    Stroke; 1994 Mar; 25(3):670-6. PubMed ID: 8128524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 19F NMR spectroscopy for measurement of cerebral blood flow: a comparative study using microspheres.
    Barranco D; Sutton LN; Florin S; Greenberg J; Sinnwell T; Ligeti L; McLaughlin AC
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):886-91. PubMed ID: 2511213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postischemic hypoperfusion in transient global ischemia: a role for endothelins?
    Patel TR; McCulloch J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S425-8. PubMed ID: 8587434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal leukocyte antibody does not decrease the injury of transient focal cerebral ischemia in cats.
    Takeshima R; Kirsch JR; Koehler RC; Gomoll AW; Traystman RJ
    Stroke; 1992 Feb; 23(2):247-52. PubMed ID: 1561656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs.
    Davis S; Helfaer MA; Traystman RJ; Hurn PD
    Stroke; 1997 Jan; 28(1):198-204; discussion 204-5. PubMed ID: 8996512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.